Helus Pharma

GH Research

This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.

Small Pharma Limited

This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.

Beckley Psytech

The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.

Delix

This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.

Mycrodose Therapeutics

This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.

Reunion Neuroscience

This biopharmaceutical company develops psychedelic-inspired therapeutic solutions for patients with underserved mental health disorders, such as postpartum depression and anxiety.

ATAI

This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.

Freedom Biosciences

The company develops ketamine and psychedelic therapeutics for patients suffering from treatment-resistant depression and other mental health conditions.